(Quartz) – Novo Nordisk and Hims had clashed on and off for months as the telehealth firm marketed compounded versions of Novo’s blockbuster GLP-1 drug Wegovy

Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will allow the telehealth company to sell Novo’s brand name weight loss drugs, sending Hims & Hers stock rocketing more than 50%. (Read More)